. 2022 Nov 24;10:1062736. doi: 10.3389/fpubh.2022.1062736
Copyright © 2022 Ling, Qin, Feng, Che, Ding and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 2.
The risk benefit in OS and PFS of drugs in and out of NRDL.